Market: NMS |
Currency: USD
Address: 4 Science Park
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut.
📈 Precipio, Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
-
-
Upside/Downside from Analyst Target:
-
-
Broker Call:
-
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
50-100%
-
Net Income Growth Range (1Y):
50-100%
-
Revenue Growth Range (1Y):
25-50%
-
Upcoming Earnings Date:
-
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for Precipio, Inc.
| Date | Reported EPS |
|---|
| 2023-11-13 | -1.04 |
| 2023-08-11 | -1.8 |
| 2023-05-12 | -2.6 |
| 2023-03-30 | -2 |
| 2022-11-10 | -2.8 |
| 2022-08-11 | -1.8 |
| 2022-05-11 | -4 |
| 2022-03-30 | -1.8 |
| 2021-11-12 | -1.6 |
| 2021-08-12 | -2.8 |
| 2021-05-14 | -1.6 |
| 2020-11-13 | -4.2 |
| 2020-08-13 | -4 |
| 2020-05-14 | -12.72 |
| 2020-03-27 | -9.6 |
| 2019-11-13 | -6.2 |
| 2019-08-09 | -21 |
📰 Related News & Research
No related articles found for "precipio inc".
